高级搜索
恶性肿瘤患者外周血细胞CD25 表达的临床意义[J]. 肿瘤防治研究, 2001, 28(02): 117-118. DOI: 10.3971/j.issn.1000-8578.2615
引用本文: 恶性肿瘤患者外周血细胞CD25 表达的临床意义[J]. 肿瘤防治研究, 2001, 28(02): 117-118. DOI: 10.3971/j.issn.1000-8578.2615
Clinical Signification on CD25+ Express of Peripheral Blood Cells in Patients with Malignant Tumors[J]. Cancer Research on Prevention and Treatment, 2001, 28(02): 117-118. DOI: 10.3971/j.issn.1000-8578.2615
Citation: Clinical Signification on CD25+ Express of Peripheral Blood Cells in Patients with Malignant Tumors[J]. Cancer Research on Prevention and Treatment, 2001, 28(02): 117-118. DOI: 10.3971/j.issn.1000-8578.2615

恶性肿瘤患者外周血细胞CD25 表达的临床意义

Clinical Signification on CD25+ Express of Peripheral Blood Cells in Patients with Malignant Tumors

  • 摘要: 目的 探讨肿瘤患者血细胞 IL- 2 R表达的临床意义。方法 用流式细胞术对 41 3例肿瘤患者血细胞 CD2 5+者进行了检测。结果 肿瘤患者血细胞 CD2 5+表达率显著低于正常对照 (P<0 .0 1 ) ;肿瘤转移者、尚未化疗者的 CD2 5+表达率显著低于非转移者、已化疗患者 (P<0 .0 1 )。结论 肿瘤可以引起血细胞 IL- 2 R表达率降低, 伴肿瘤转移者更低 ;化疗可提高患者血细胞 IL- 2 R表达率。

     

    Abstract: Objective To study clinical signification of IL-2R express on peripheral blood cells of patients with malignant tumors. Methods CD25\++cells percentage rate were measured in peripheral blood lymphcyte from 413 patients with malignant tumors by flow cytometry. Results CD25\++cells percentage rate of patients with malignant tumors were lower than this of normal contral group (P<0.01).CD25\++ percentage rate of patients with tumor metastase and with no-chemotherapy were lower than this of patients with tumo...

     

/

返回文章
返回